In conclusion, the antitumor activity of CD24+MDSC-DCs was achieved by inhibiting the polarization of CD4+T cells toward Tregs, therefore reducing the proportion of Treg in tumor and changing the immunosuppression of TME. The gene discussed is CD4; the disease is neoplasm.